Ken Griffin (Citadel Advisors) exit Royalty Pharma plc
Ken Griffin (Citadel Advisors) exit $-207.1M of disclosed value in Royalty Pharma plc.
Signal
Investor Move
Action
Exit
Capital
$-207.1M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.